Check-Cap(CHEK) - 2023 Q1 - Quarterly Report

Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results ISFIYA, Israel, March 31, 2023 -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparationfree screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced financial results for the fourth quarter and full year ended December 31, 2022. • In Marc ...